Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.
published in: Cancer Letters
date of publication: 2016-05-20
language: English
main subject: cholangiocarcinoma, xenograft
Cites articles 38
- 2014-06-21
Date
Title
Article - wd:Q41670809